Catalyst
Monitor trial results and any announcements regarding the efficacy of SPI-1005 compared to placebo, as well as potential regulatory filings.
Date
June 29, 2026
Phase
N/A
Status
watch
Signal score
7.0
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.